The 2 analysts offering 12-month price forecasts for Brickell Biotech Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +391.07% increase from the last price of 1.12.
The current consensus among 2 polled investment analysts is to Buy stock in Brickell Biotech Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.09
Reporting Date Mar 24
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.